Axa’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-140,596
| Closed | -$2.21M | – | 1129 |
|
|
2024
Q3 | $2.21M | Buy |
140,596
+12,196
| +9% | +$185K | 0.01% | 726 |
|
|
2024
Q2 | $1.73M | Hold |
128,400
| – | – | 0.01% | 792 |
|
|
2024
Q1 | $3.56M | Hold |
128,400
| – | – | 0.01% | 642 |
|
|
2023
Q4 | $2.47M | Buy |
128,400
+2,900
| +2% | +$52.5K | 0.01% | 696 |
|
|
2023
Q3 | $2.03M | Sell |
125,500
-2,900
| -2% | -$51.5K | 0.01% | 707 |
|
|
2023
Q2 | $2.44M | Sell |
128,400
-172,521
| -57% | -$3.08M | 0.01% | 683 |
|
|
2023
Q1 | $4.38M | Sell |
300,921
-93,172
| -24% | -$1.67M | 0.02% | 596 |
|
|
2022
Q4 | $7.7M | Buy |
394,093
+123,765
| +46% | +$2.41M | 0.03% | 494 |
|
|
2022
Q3 | $6.51M | Buy |
270,328
+137,185
| +103% | +$4.23M | 0.03% | 524 |
|
|
2022
Q2 | $4.19M | Sell |
133,143
-30,557
| -19% | -$1.11M | 0.02% | 626 |
|
|
2022
Q1 | $7.21M | Buy |
163,700
+5,800
| +4% | +$249K | 0.02% | 553 |
|
|
2021
Q4 | $6.87M | Sell |
157,900
-13,400
| -8% | -$525K | 0.02% | 585 |
|
|
2021
Q3 | $5.36M | Buy |
171,300
+29,600
| +21% | +$1.16M | 0.02% | 661 |
|
|
2021
Q2 | $6M | Sell |
141,700
-41,300
| -23% | -$1.61M | 0.02% | 656 |
|
|
2021
Q1 | $6.88M | Sell |
183,000
-47,700
| -21% | -$1.49M | 0.02% | 621 |
|
|
2020
Q4 | $6.24M | Buy |
230,700
+2,600
| +1% | +$66.9K | 0.02% | 646 |
|
|
2020
Q3 | $5.73M | Buy |
+228,100
| New | +$3.33M | 0.02% | 587 |
|
|
2019
Q2 | – | Sell |
-13,500
| Closed | -$55K | – | 1336 |
|
|
2019
Q1 | $55K | Hold |
13,500
| – | – | ﹤0.01% | 1305 |
|
|
2018
Q4 | $85K | Sell |
13,500
-5,600
| -29% | -$58.1K | ﹤0.01% | 1281 |
|
|
2018
Q3 | $316K | Sell |
19,100
-32,600
| -63% | -$554K | ﹤0.01% | 1219 |
|
|
2018
Q2 | $864K | Sell |
51,700
-65,100
| -56% | -$1.05M | ﹤0.01% | 1039 |
|
|
2018
Q1 | $1.82M | Sell |
116,800
-209,216
| -64% | -$3.73M | 0.01% | 878 |
|
|
2017
Q4 | $6.16M | Buy |
326,016
+55,000
| +20% | +$1.22M | 0.02% | 603 |
|
|
2017
Q3 | $7.91M | Buy |
271,016
+28,616
| +12% | +$845K | 0.03% | 510 |
|
|
2017
Q2 | $7.8M | Sell |
242,400
-15,100
| -6% | -$496K | 0.04% | 493 |
|
|
2017
Q1 | $8.91M | Buy |
257,500
+13,000
| +5% | +$464K | 0.04% | 448 |
|
|
2016
Q4 | $8.63M | Buy |
244,500
+27,600
| +13% | +$933K | 0.04% | 443 |
|
|
2016
Q3 | $7.53M | Buy |
216,900
+700
| +0.3% | +$24.5K | 0.03% | 486 |
|
|
2016
Q2 | $8.08M | Sell |
216,200
-16,900
| -7% | -$635K | 0.04% | 446 |
|
|
2016
Q1 | $9.42M | Buy |
233,100
+60,300
| +35% | +$2.25M | 0.04% | 408 |
|
|
2015
Q4 | $6.22M | Buy |
172,800
+8,100
| +5% | +$293K | 0.03% | 499 |
|
|
2015
Q3 | $5.26M | Buy |
164,700
+19,300
| +13% | +$657K | 0.02% | 552 |
|
|
2015
Q2 | $4.94M | Buy |
145,400
+10,600
| +8% | +$357K | 0.02% | 602 |
|
|
2015
Q1 | $4.56M | Sell |
134,800
-5,900
| -4% | -$206K | 0.02% | 622 |
|
|
2014
Q4 | $4.94M | Buy |
140,700
+45,200
| +47% | +$1.52M | 0.02% | 559 |
|
|
2014
Q3 | $3.13M | Buy |
95,500
+3,200
| +3% | +$109K | 0.01% | 639 |
|
|
2014
Q2 | $3.14M | Buy |
92,300
+2,600
| +3% | +$89.1K | 0.01% | 669 |
|
|
2014
Q1 | $3.14M | Buy |
89,700
+89,390
| +28,835% | +$3.15M | 0.01% | 646 |
|
|
2013
Q4 | $11K | Sell |
310
-14,909
| -98% | -$547K | ﹤0.01% | 1363 |
|
|
2013
Q3 | $526K | Hold |
15,219
| – | – | ﹤0.01% | 994 |
|
|
2013
Q2 | $515K | Buy |
+15,219
| New | +$505K | ﹤0.01% | 958 |
|
Other funds holding ACH
DM
CCM
Axa's ACH Position: Q4 2024 in Review
Axa sold out of Accendra Health (ACH) in Q4 2024, closing a stake of 140,596 shares — an estimated $2.21M sold.
Axa first reported a position in ACH in Q2 2013 and held it in 41 quarters. The position peaked at $9.42M in Q1 2016. 198 funds tracked by Wall St. Rank hold ACH as of Q4 2024.
- Axa reported no remaining Accendra Health position as of Q4 2024 after selling out during the quarter.
- Axa sold 140,596 Accendra Health shares in Q4 2024, an estimated $2.21M.
- Axa first reported a position in Accendra Health in Q2 2013 and held it in 41 quarters.
- Axa's Accendra Health position peaked at $9.42M in Q1 2016.
- 198 funds tracked by Wall St. Rank held Accendra Health as of Q4 2024.
Based on Axa's 13F filing for Q4 2024, filed 14 Feb 2025.